Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure.
about
Debate: Statins should be used in patients with heart failureStatins in the treatment of chronic heart failure: a systematic reviewAssociation of body mass index with outcomes in patients with CKD.Lipids, statins, and clinical outcomes in heart failure: rethinking the data.Vasodilator effect of endothelin in cutaneous microcirculation of heart failure patients.Nutritional and anti-inflammatory interventions in chronic heart failure.Cachexia in malaria and heart failure: therapeutic considerations in clinical practice.Cardiac cachexia.Adiponectin protects against the development of systolic dysfunction following myocardial infarction.A meta-analysis of proinflammatory cytokines in chronic heart failure.Prognostic Significance of Biomarkers in Pulmonary Arterial Hypertension.Cardioprotection by adiponectin.The kidney disease wasting: inflammation, oxidative stress, and diet-gene interaction.Why cachexia kills: examining the causality of poor outcomes in wasting conditions.The cholesterol paradox in heart failure.Low serum triglyceride levels as predictors of cardiac death in heart failure patients.Anti-oxidative and cholesterol efflux capacities of high-density lipoprotein are reduced in ischaemic cardiomyopathy.Infection-induced coronary dysfunction and systemic inflammation in piglets are dampened in hypercholesterolemic milieu.Cachexia in chronic heart failure: endocrine determinants and treatment perspectives.Mechanisms for cachexia in heart failure.Obesity in heart failure: impact on survival and treatment modalities.Statin therapy in heart failure: for good, for bad, or indifferent?The effects of a high-caloric protein-rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers: a randomized, double-blind pilot studyCholesterol is required for maintaining T-tubule integrity and intercellular connections at intercalated discs in cardiomyocytesCardiac troponin T as a predictor of cardiac death in patients with left ventricular dysfunctionα-Defensins and outcome in patients with chronic heart failure.Metalloproteinases 2 and 9 are increased in plasma of patients with heart failure.Association of HDL cholesterol and triglycerides with mortality in patients with heart failure.High levels of C-reactive protein with low total cholesterol concentrations additively predict all-cause mortality in patients with coronary artery disease.A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics.The effect of different preparations of hormone therapy on tumor necrosis factor-alpha levels in women with surgical menopause.The Role of Toll-Like Receptor Signaling in the Progression of Heart Failure.Acute Heart Failure developed as worsening of Chronic Heart Failure is associated with increased mortality compared to de novo cases.
P2860
Q24799320-0B08AF28-B058-46E0-B460-23033E63F689Q28200294-C263586C-642F-4A1E-A485-2F94AA03E7A3Q30371128-6B98A3A1-1888-413A-8C23-FCBBD07435FEQ30752824-5226932C-3826-44E0-B843-AA4AFC1E2507Q30791568-B1DE100C-DB69-4FBA-8C82-B717CEE1E4A0Q33880185-3BD8503C-03F0-46EE-836F-F37015067521Q35520657-9B50240C-4D3E-4DB5-B633-4BFAD2F62470Q35932382-CB4EC69E-8AFE-4236-B584-504FD1454D3DQ36004798-A41C59CE-3347-4C1E-B16A-F2F14874A1FDQ36057476-1ABFB08A-A2BC-4B54-BA5D-EE519F6A28EBQ36490165-764952BC-A66A-4DBE-B305-CBD022A36BFFQ36510181-9DE42D75-EDA7-4B61-8D13-A50D91606BAFQ36609845-0B60B4EB-BFBC-408C-BAC2-A4EB2F4342ACQ36934999-E5122747-65A4-44A6-8710-50D311384B68Q37018475-8709AA0A-C139-47B8-B21E-E8136C7B57EFQ37370010-740B0E83-0F60-4A62-AC53-0D56824A513DQ37464185-41141F6D-A75A-4242-A1D1-2A719A252DB5Q37851309-5111BF74-9DE8-4DA6-9C61-FB1DB6AAF4F4Q38035745-9876F9A1-CB2F-4644-B41F-B7F387FAE1C3Q38127358-56B58643-7EEB-4126-A932-698F18A9CA1CQ38128922-EC1957D4-BA88-43FB-8729-0E0BC8561552Q38166321-9634D37B-C3EF-4039-9DC5-152D0CB30991Q38492490-5B2F4337-AE73-45B7-B8CC-50B49985FD40Q39714305-74026B01-D6CB-4E9C-A4E4-BB4B1ED69B99Q42265921-B94796AE-AFA0-477D-9474-72F76328D251Q43415576-59F4F0F1-2C04-41C6-9E41-58CC136EB782Q44514122-E2B8878A-E580-46C1-A7F1-A68E07CD823AQ44780117-036D5787-3242-4C88-9CB8-0F1D3F44FE6FQ45236219-5DDBBD70-C1B8-4D35-9169-081EC2B465A0Q46755100-77E8FFFB-CE1D-4FD1-9A5B-B2E44ADD33FAQ46797831-6F78FB99-8FA2-4967-8BB7-A394DAFBE50FQ52632607-AFA82018-849C-4C86-990F-4E1010B18C48Q55427859-E80D0297-8357-476F-95B5-20A463D68C92
P2860
Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Inflammatory cytokines and the ...... eins in chronic heart failure.
@en
Inflammatory cytokines and the ...... eins in chronic heart failure.
@nl
type
label
Inflammatory cytokines and the ...... eins in chronic heart failure.
@en
Inflammatory cytokines and the ...... eins in chronic heart failure.
@nl
prefLabel
Inflammatory cytokines and the ...... eins in chronic heart failure.
@en
Inflammatory cytokines and the ...... eins in chronic heart failure.
@nl
P2093
P1476
Inflammatory cytokines and the ...... eins in chronic heart failure.
@en
P2093
Francis DP
Koloczek V
Niebauer J
Rauchhaus M
P304
P356
10.1016/S0167-5273(00)00224-2
P407
P577
2000-11-01T00:00:00Z